Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial.
Overview publication
| Title | Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): 1-year follow-up results of a randomised controlled trial. |
| Date | 2024-09-01 |
| Issue name | The European respiratory journal |
| Issue number | v64.3 |
| DOI | 10.1183/13993003.01368-2024 |
| PubMed | 39231630 |
| Authors | |
| Read | Read publication |